MyAverix Finance
US · Healthcare
CERo Therapeutics Holdings, Inc. Common Stock (CERO)
Biotechnology
CERo Therapeutics Holdings, Inc. Common Stock (CERO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CERO
CERo Therapeutics Holdings, Inc. Common Stock (CERO) — FAQ
What is CERO's P/E ratio?
The price-to-earnings (P/E) ratio for CERo Therapeutics Holdings, Inc. Common Stock (CERO) is 25.00 (data as of 2026-05-23).
Does CERo Therapeutics Holdings, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for CERo Therapeutics Holdings, Inc. Common Stock (CERO). Check the MyAverix Finance app for the latest dividend data.
What sector is CERo Therapeutics Holdings, Inc. Common Stock in?
CERo Therapeutics Holdings, Inc. Common Stock (CERO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CERO listed on?
CERO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.